2022 Annual
February 8, 2023
US startup valuations remained high in 2022, but trend isn’t a friend
Despite it all—a vulnerable market in flux, an IPO freeze and rising geopolitical tensions—valuations for US-based startups remained strong. Yet it does depend on where you look, and the positive trend may soon change. Records were broken in 2022, both good and otherwise.
Our 2022 Annual US VC Valuations report, sponsored by Morgan Stanley at Work and Reitler, has all the figures and charts to make sense of the year.
Key takeaways
Key takeaways | 4 |
Angel and seed | 5 |
Early-stage VC valuations | 7 |
Late-stage VC valuations | 9 |
A word from Morgan Stanley at Work | 11 |
Venture-growth valuations | 13 |
Biotech & pharma | 15 |
Fintech | 16 |
Enterprise tech | 17 |
Consumer tech | 18 |
A word from Reitler | 19 |
Nontraditional investors | 21 |
Liquidity | 23 |
Deal terms | 25 |